Precigen (PGEN) Current Deferred Revenue: 2012-2024
Historic Current Deferred Revenue for Precigen (PGEN) over the last 13 years, with Dec 2024 value amounting to $2.5 million.
- Precigen's Current Deferred Revenue fell 76.42% to $575,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $575,000, marking a year-over-year decrease of 76.42%. This contributed to the annual value of $2.5 million for FY2024, which is 8.42% up from last year.
- Precigen's Current Deferred Revenue amounted to $2.5 million in FY2024, which was up 8.42% from $2.3 million recorded in FY2023.
- In the past 5 years, Precigen's Current Deferred Revenue ranged from a high of $24.5 million in FY2021 and a low of $1.8 million during FY2022.
- In the last 3 years, Precigen's Current Deferred Revenue had a median value of $2.3 million in 2023 and averaged $2.2 million.
- Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 250.54% in 2021, then plummeted by 92.48% in 2022.
- Yearly analysis of 5 years shows Precigen's Current Deferred Revenue stood at $7.0 million in 2020, then surged by 250.54% to $24.5 million in 2021, then slumped by 92.48% to $1.8 million in 2022, then grew by 26.26% to $2.3 million in 2023, then climbed by 8.42% to $2.5 million in 2024.